Article
LOX and ACSL5 as potential relapse markers for pancreatic cancer patients
3 Feb 2019
Abstract excerpt
Pancreatic cancer is one of the most malignant diseases and has a poor prognosis. The screening and validation of biomarkers with predictive value for prognosis and treatment efficacy are important. To identify potential prognostic markers of pancreatic cancer patients, we conducted a study that included 99 pancreatic cancer patients. Three patients with PFS>18 months were enrolled in the treat group, and three...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
